JP2024524895A5 - - Google Patents

Info

Publication number
JP2024524895A5
JP2024524895A5 JP2023576368A JP2023576368A JP2024524895A5 JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5 JP 2023576368 A JP2023576368 A JP 2023576368A JP 2023576368 A JP2023576368 A JP 2023576368A JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
sequence described
csp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033877 external-priority patent/WO2022266383A1/en
Publication of JP2024524895A publication Critical patent/JP2024524895A/ja
Publication of JP2024524895A5 publication Critical patent/JP2024524895A5/ja
Pending legal-status Critical Current

Links

JP2023576368A 2021-06-17 2022-06-16 抗csp抗体 Pending JP2024524895A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163211820P 2021-06-17 2021-06-17
US63/211,820 2021-06-17
PCT/US2022/033877 WO2022266383A1 (en) 2021-06-17 2022-06-16 Anti-csp antibodies

Publications (2)

Publication Number Publication Date
JP2024524895A JP2024524895A (ja) 2024-07-09
JP2024524895A5 true JP2024524895A5 (cg-RX-API-DMAC7.html) 2025-06-23

Family

ID=84526612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576368A Pending JP2024524895A (ja) 2021-06-17 2022-06-16 抗csp抗体

Country Status (9)

Country Link
US (2) US11655290B2 (cg-RX-API-DMAC7.html)
EP (1) EP4355774A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024524895A (cg-RX-API-DMAC7.html)
KR (1) KR20240047964A (cg-RX-API-DMAC7.html)
CN (1) CN117940450A (cg-RX-API-DMAC7.html)
AU (2) AU2022292722B2 (cg-RX-API-DMAC7.html)
IL (1) IL309422A (cg-RX-API-DMAC7.html)
MX (1) MX2023014984A (cg-RX-API-DMAC7.html)
WO (1) WO2022266383A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322413A (en) * 2023-02-03 2025-09-01 Atreca Inc Variants of anti-CSP antibody
WO2025194069A1 (en) * 2024-03-15 2025-09-18 Atreca, Inc. Anti-csp antibody variants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3954643B2 (ja) 1991-11-16 2007-08-08 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム マラリア原虫由来のCSおよびHBsAG間のハイブリッド蛋白質
JP4334141B2 (ja) 1998-04-20 2009-09-30 グリカート バイオテクノロジー アクチェンゲゼルシャフト 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US9221902B2 (en) * 2008-11-07 2015-12-29 Fabrus, Inc. Combinatorial antibody libraries and uses thereof
SG10201900183VA (en) * 2011-04-28 2019-05-30 Univ Leland Stanford Junior Identification of polynucleotides associated with a sample
KR20180029253A (ko) * 2015-07-22 2018-03-20 유레카 쎄라퓨틱스, 인코포레이티드 Psa 펩티드/mhc 복합체를 표적화하는 구축물 및 그의 용도
US11066464B2 (en) * 2016-03-21 2021-07-20 Kymab Limited Anti-malarial antibodies that bind circumsporozoite protein
US20220195023A1 (en) 2019-02-19 2022-06-23 Atreca, Inc. Anti-csp antibody variants

Similar Documents

Publication Publication Date Title
JP2024167313A5 (cg-RX-API-DMAC7.html)
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2024150751A5 (cg-RX-API-DMAC7.html)
JP2018535650A5 (cg-RX-API-DMAC7.html)
JP2025032102A5 (cg-RX-API-DMAC7.html)
JP2020506898A5 (cg-RX-API-DMAC7.html)
JP2020519643A5 (cg-RX-API-DMAC7.html)
JP2023505492A5 (cg-RX-API-DMAC7.html)
JP2022169589A5 (cg-RX-API-DMAC7.html)
JP2020509756A5 (cg-RX-API-DMAC7.html)
JP2022530404A5 (cg-RX-API-DMAC7.html)
JP2020515518A5 (cg-RX-API-DMAC7.html)
JP2017500018A5 (cg-RX-API-DMAC7.html)
AU2005214988A1 (en) Super-humanized antibodies against respiratory syncytial virus
JP2005510246A5 (cg-RX-API-DMAC7.html)
JP2024527288A5 (cg-RX-API-DMAC7.html)
JP2016529229A5 (cg-RX-API-DMAC7.html)
JP2018510617A5 (cg-RX-API-DMAC7.html)
RU2009136677A (ru) Рекомбинантные антитела для лечения респираторно-синцитиальных вирусных инфекций
JP2022512647A5 (cg-RX-API-DMAC7.html)
CN106795219A (zh) 抗il‑17抗体及其生产和使用的方法
JP2022542670A5 (cg-RX-API-DMAC7.html)
JP2015524790A5 (cg-RX-API-DMAC7.html)
JP2010501164A5 (cg-RX-API-DMAC7.html)
JP2004502421A5 (cg-RX-API-DMAC7.html)